SCHEMBL20525537

SCHEMBL20525537

COc1c(OCC2CCN(C)CC2)ccc2c(Oc3ccc(NC(=O)C(=O)NCC(C)c4ccccc4)cc3F)ccnc12

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MET P08581 15/20 0.52
KDR P35968 4/20 0.40
EGFR P00533 3/20 0.40
IGF1R P08069 3/20 0.40
FLT3 P36888 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525800 0.92 MET (0.51) METKDREGFRFLT3
SCHEMBL20525679 0.91 MET (0.51) METKDRIGF1RFLT3
SCHEMBL20525607 0.90 MET (0.58) METKDRIGF1RFLT3
SCHEMBL20525821 0.89 MET (0.54) METKDRIGF1RFLT3
SCHEMBL20525606 0.89 MET (0.50) METKDRFLT3
SCHEMBL372578 0.88 MET (0.67) METKDRFLT3
SCHEMBL372579 0.88 MET (0.67) METKDRFLT3
SCHEMBL20525632 0.87 MET (0.53) METKDREGFRFLT3
SCHEMBL20525820 0.87 MET (0.51) METKDRIGF1R
SCHEMBL20525668 0.86 MET (0.52) METKDRIGF1RFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed